Literature DB >> 7821422

A novel pancreatic beta-cell isoform of calcium/calmodulin-dependent protein kinase II (beta 3 isoform) contains a proline-rich tandem repeat in the association domain.

V Urquidi1, S J Ashcroft.   

Abstract

There is evidence for a role for calcium/calmodulin-dependent protein phosphorylation in regulation of insulin secretion but the molecular nature of the kinase(s) responsible is unknown. In this study, the screening of a neonatal rat islet cDNA library resulted in the isolation of a 2 kb clone that was 99% homologous to the beta' isoform of calcium/calmodulin-dependent protein kinase II. The predicted 589 amino acid sequence with a calculated mass of 64,976 Da contained a 24 amino acid deletion in addition to the 15 amino acid deletion that differentiates the beta' from the beta isoform, and included an 86 amino acid novel domain consisting of a tandem repeat of proline-rich residues. The expression of this new isoform of calcium/calmodulin-dependent protein kinase II (beta 3) was confirmed in beta-cell lines and testis by DNA amplification of the sequence encoding the inserted domain by reverse transcriptase-polymerase chain reaction, followed by Southern analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821422     DOI: 10.1016/0014-5793(94)01381-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II.

Authors:  Andy Hudmon; Howard Schulman
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Alternative splicing modulates the frequency-dependent response of CaMKII to Ca(2+) oscillations.

Authors:  K Ulrich Bayer; Paul De Koninck; Howard Schulman
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

3.  Muscarinic activation of Ca2+/calmodulin-dependent protein kinase II in pancreatic islets. Temporal dissociation of kinase activation and insulin secretion.

Authors:  E L Babb; J Tarpley; M Landt; R A Easom
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

4.  Group VIA phospholipase A2 forms a signaling complex with the calcium/calmodulin-dependent protein kinase IIbeta expressed in pancreatic islet beta-cells.

Authors:  Zhepeng Wang; Sasanka Ramanadham; Zhongmin Alex Ma; Shunzhong Bao; David J Mancuso; Richard W Gross; John Turk
Journal:  J Biol Chem       Date:  2004-12-02       Impact factor: 5.157

5.  CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing.

Authors:  Heather O'Leary; Erika Lasda; K Ulrich Bayer
Journal:  Mol Biol Cell       Date:  2006-08-23       Impact factor: 4.138

6.  Alternative splicing generates a CaM kinase IIbeta isoform in myocardium that targets the sarcoplasmic reticulum through a putative alphaKAP and regulates GAPDH.

Authors:  Puneet Singh; John J Leddy; George J Chatzis; Maysoon Salih; Balwant S Tuana
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

7.  alphaKAP is an anchoring protein for a novel CaM kinase II isoform in skeletal muscle.

Authors:  K U Bayer; K Harbers; H Schulman
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

Review 8.  Ca2+/calmodulin-dependent protein kinase II function in vascular remodelling.

Authors:  Harold A Singer
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

Review 9.  Regulation of CaMKII in vivo: the importance of targeting and the intracellular microenvironment.

Authors:  Kathryn A Skelding; John A P Rostas
Journal:  Neurochem Res       Date:  2009-05-05       Impact factor: 3.996

10.  Analysis of the CaMKIIα and β splice-variant distribution among brain regions reveals isoform-specific differences in holoenzyme formation.

Authors:  Sarah G Cook; Ashley M Bourke; Heather O'Leary; Vincent Zaegel; Erika Lasda; Janna Mize-Berge; Nidia Quillinan; Chandra L Tucker; Steven J Coultrap; Paco S Herson; K Ulrich Bayer
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.